Notable Analyst Rating Changes 4/27: BUCY, JOYG, MMM, NFLX Upgraded; BNI, HON, MAR, SONC Downgraded
More News related to AZN
- AstraZeneca (AZN) Gets U.S. FDA Approval for SEROQUEL XR Antidepressants
- US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
- Morning Movers 12/03: ICOC, KTCC, FFHL, GNBT, ABK, ISR Higher; PEIX, GRH, OPXA, TRGT, ALOY Lower
- AstraZeneca (AZN) and Targacept (TRGT) To Collaborate to Develop and Commercialize TC-5214 MDD Drug
- Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013
More News related to BNI
- The "Buy Stuff" Bell Is Ringing, Are You Listening?
- USG Corp (USG) Up On Talk Buffett Will Buy Remaining Shares
- BNSF Statement on State of Montana Lawsuit on Shortline Rail Issues
- BNSF Honors Plainsman Switching Company for Partnership Excellence
- BNSF Honors Burlington Junction Railway for Partnership Excellence
More News related to BUCY
- Goldman Sachs Raises Price Target on Deere & Co (DE) to $57
- Bucyrus to Present at Robert W. Baird & Co. Conference
- Bucyrus to Present at Goldman Sachs Industrials Conference
- Bucyrus International Up After BUYINS.NET Report Predicted Strength After Earnings
- Morning Movers 10/23: AMZN, CPWR, EPAY, ALGN, HWAY, SCSS, ACO Higher; ELN, SNV, CBRX, RMTR, STSA, DVAX Lower
More News related to Special Reports
- JANCO Partners Downgrades Energy Conversion Devices (ENER) to Sell
- Feltl & Co. Downgrades ArcSight (ARST) to Sell
- Credit Suisse Downgrades Comcast (CMCSA) to Neutral
- Citi Downgrades AK Steel (AKS) to Hold
- Citi Downgrades Netflix (NFLX) to Hold
UPGRADES:
Goldman Sachs upgrades Bucyrus International (Nasdaq: BUCY) and Joy Global (Nasdaq: JOYG) from Neutral to Buy, with a $23 and $32 price target respectively.
Barclays upgrades 3M (NYSE: MMM) from Underweight to Equalweight. Price target increased from $41 to $62.
Citi upgrades Netflix Inc (Nasdaq: NFLX) from Hold to Buy. Price target increased from $37 to $52. Click here for more color.
UBS upgrades AstraZeneca (NYSE: AZN) from Neutral to Buy.
Piper Jaffray upgrades DaVita Inc. (NYSE: DVA) from Neutral to Buy. Price target $57. Click here for the full report.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citi downgrades Burlington Northern (NYSE: BNI) from Hold to Sell. Price target raised $3 to $61.Click here for more color.
Citi downgrades Honeywell International Inc (NYSE: HON) from Buy to Hold. Price target lowered from $41 to $34. Click here for the full report.
UBS downgrades Marriott (NYSE: MAR) from Buy to Neutral.
Goldman Sachs downgrades Sonic Corp. (Nasdaq: SONC) from Neutral to Sell.
Goldman Sachs downgrades TIBCO (Nasdaq: TIBX) from Buy to Neutral, maintaing a $7.50 price target.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Piper Jaffray initiates coverage on Dolan Media (NYSE: DM) with a Buy. Price target $15. Here is the full report.
Baird initiates coverage on RC2 (Nasdaq: RCRC) with an Outperform rating. Price target $12.
J.P. Morgan initiates coverage on Thompson Creek (NYSE: TC) with an Overweight.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+0.68
-1.01Related Entities
- Piper Jaffray
- UBS
- JPMorgan
- Goldman Sachs
- Citi
- Robert W Baird
- Barclays
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
